UNLIMITED

STAT

Opinion: Ending tuberculosis: we can get there with a new roadmap

The Lancet Commission has set an audacious goal of achieving a world that's free of #TB within a generation. We will need new tools and strategies to get there. #WorldTBDay
Scientists work in the tuberculosis research laboratory of the Pasteur Institute in 1938. The only licensed TB vaccine today, the Bacille Calmette-Guerin vaccine, was developed 17 years earlier.

Two recent events have nudged tuberculosis, the leading infectious cause of death around the word, onto the world stage. The first was the World Health Organization’s Global Ministerial Conference on Ending TB, which was held in Moscow in 2017. The second was the United Nations High Level Meeting on tuberculosis in September 2018. At that seminal gathering of national leaders, a political declaration laid out two goals to achieve by 2022: prevent at least 30 million people from becoming ill with TB, and successfully treating 40 million people who are already infected with the disease.

That’s an audacious goal, especially given the fact that most of the tools currently available to prevent,

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
Opinion: In A Threat To Patient Trust, Texas Hospitals Must Ask ‘Are You A U.S. Citizen?’
Akshara Ramasamy will soon begin medical school in Texas — but the state’s new requirement to ask hospital patients about immigration status worries her.
STAT1 min read
STAT+: How Invisible Medical Groups Are Powering Telehealth’s GLP-1 ‘Gold Rush’
Telehealth sites prescribing GLP-1s online can get off the ground in a matter of days by “renting” the services of these medical groups.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Medicare Obesity Drug Coverage, A First-of-its-kind 340B Analysis, And More
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound

Related Books & Audiobooks